This hybrid event highlights key milestones in BRCA1 and BRCA2 research, featuring insights from Dr. Steven Narod of Women’s College Hospital. It explores advancements in managing breast and ovarian cancer risks, hosted by The Peter Gilgan Centre for Women’s Cancers with support from AstraZeneca and Merck.
Watch the full recordings here to learn more about this impactful journey.